Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 26, 2005
Primary aldosteronism combined with preclinical Cushing's syndrome in an elderly patientHideki Fujii, Kei Kamide, Osamu Miyake, et al.
Journal of Endourology|September 30, 2005
Retroperitoneoscopic living related-donor nephrectomy: clinical outcomes of 50 consecutive cases and comparison with open donor nephrectomyKazuhiro Yoshimura, Shiro Takahara, Miyaji Kyakuno, et al.
Journal of Bone and Mineral Metabolism|May 13, 2022
Assessment of bone health in patients with prostate cancer using cancer staging computed tomographyMototaka Sato, Masafumi Kashii, Atsuki Matsukawa, et al.
International Journal of Clinical Oncology|August 11, 2018
Results of weekday-on and weekend-off administration schedule of sunitinib therapy for advanced renal cell carcinomaAtsunari Kawashima, Motohide Uemura, Taigo Kato, et al.
Early Human Development|November 27, 2012
Metabolomics analysis of umbilical cord blood clarifies changes in saccharides associated with delivery methodFusako Hashimoto, Shin Nishiumi, Osamu Miyake, et al.
Advances in Urology|February 23, 2024
Lower Dose of 5 mL of 1% Lidocaine is More Suitable than the Conventional 10 mL for Caudal Block in Transrectal Prostate Biopsy: A Retrospective Cohort StudyNorichika Ueda, Mototaka Sato, Shunsuke Mori, et al.
BJUI Compass|May 4, 2026
Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancerYu Ishizuya, Atsunari Kawashima, Shimpei Yamashita, et al.
International Journal of Clinical Oncology|September 2, 2024
Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in JapanAkihiro Yoshimura, Taigo Kato, Yasutomo Nakai, et al.
Scientific Reports|December 12, 2025
Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective studyTaigo Kato, Yasutomo Nakai, Mototaka Sato, et al.
Pageof 4